Literature DB >> 10694325

Interleukin 1 receptor antagonist gene polymorphism in women with vulvar vestibulitis.

J Jeremias1, W J Ledger, S S Witkin.   

Abstract

OBJECTIVE: Vulvar vestibulitis is a chronic inflammatory syndrome of unknown cause and pathogenesis. We examined the relation between vulvar vestibulitis and polymorphisms in the gene coding for the interleukin 1 receptor antagonist, a naturally occurring down-regulator of proinflammatory immune responses. STUDY
DESIGN: Cells from the lower genital tract of 68 women with vulvar vestibulitis, 343 women with no history of vulvodynia, and 40 women with human papillomavirus cervical infection were tested by polymerase chain reaction for the different alleles of the gene encoding for interleukin 1 receptor antagonist. The presence of human papillomavirus in the specimens was determined by polymerase chain reaction with the use of degenerate consensus primers to the conserved L1 gene.
RESULTS: Allele 2 of the gene encoding the interleukin 1 receptor antagonist was present in homozygous form in 52.9% of women with vulvar vestibulitis. In marked contrast only 8. 5% of the control women and 2.5% of women with human papillomavirus were homozygous for this allele (P </=.0001). Among the women with vulvar vestibulitis, 57.5% of those without human papillomavirus, as well as 52.2% of those with human papillomavirus, were homozygous for allele 2 of the gene encoding interleukin 1 receptor antagonist.
CONCLUSION: The unique distribution of interleukin 1 receptor antagonist alleles among women with vulvar vestibulitis suggests that polymorphism in this gene may be a factor influencing susceptibility to this syndrome, severity of symptoms, or both.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10694325     DOI: 10.1016/s0002-9378(00)70212-2

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  16 in total

1.  Vulvar Vestibulitis Syndrome: A Post-infectious Entity?

Authors: 
Journal:  Curr Infect Dis Rep       Date:  2000-12       Impact factor: 3.725

Review 2.  [Review of the literature on the psychoemotional reality of women with vulvodynia: difficulties met and strategies developed].

Authors:  M Cantin-Drouin; D Damant; D Turcotte
Journal:  Pain Res Manag       Date:  2008 May-Jun       Impact factor: 3.037

3.  Genetic polymorphisms of surfactant protein D rs2243639, Interleukin (IL)-1β rs16944 and IL-1RN rs2234663 in chronic obstructive pulmonary disease, healthy smokers, and non-smokers.

Authors:  Marianne Samir M Issac; Wafaa Ashur; Heba Mousa
Journal:  Mol Diagn Ther       Date:  2014-06       Impact factor: 4.074

4.  Interleukin-1 receptor antagonist gene polymorphism and circulating levels of human immunodeficiency virus type 1 RNA in Brazilian women.

Authors:  S S Witkin; I M Linhares; S Gerber; M E Caetano; A C Segurado
Journal:  J Virol       Date:  2001-07       Impact factor: 5.103

5.  Innate Immune System Gene Polymorphisms in Women with Vulvovaginal Infections.

Authors:  Mehmet R Genç; Andrew Onderdonk; Steven S Witkin
Journal:  Curr Infect Dis Rep       Date:  2004-12       Impact factor: 3.725

6.  The bacterial microbiome in paired vaginal and vestibular samples from women with vulvar vestibulitis syndrome.

Authors:  Aswathi Jayaram; Steven S Witkin; Xia Zhou; Celeste J Brown; Gustavo E Rey; Iara M Linhares; William J Ledger; Larry J Forney
Journal:  Pathog Dis       Date:  2014-07-10       Impact factor: 3.166

7.  Interleukin-1 receptor antagonist gene polymorphism, vaginal interleukin-1 receptor antagonist concentrations, and vaginal ureaplasma urealyticum colonization in pregnant women.

Authors:  Parrin T Barton; Stefan Gerber; Daniel W Skupski; Steven S Witkin
Journal:  Infect Immun       Date:  2003-01       Impact factor: 3.441

8.  Allergic reactions and risk of vulvodynia.

Authors:  Bernard L Harlow; Wei He; Ruby H N Nguyen
Journal:  Ann Epidemiol       Date:  2009-11       Impact factor: 3.797

Review 9.  Progress in genetic studies of pain and analgesia.

Authors:  Michael L Lacroix-Fralish; Jeffrey S Mogil
Journal:  Annu Rev Pharmacol Toxicol       Date:  2009       Impact factor: 13.820

10.  Environmental Exposure History and Vulvodynia Risk: A Population-Based Study.

Authors:  Barbara D Reed; Kimberly S McKee; Melissa A Plegue; Sung Kyun Park; Hope K Haefner; Sioban D Harlow
Journal:  J Womens Health (Larchmt)       Date:  2018-10-10       Impact factor: 2.681

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.